Bristol-Myers Squibb sell Barclays PLC
Start price
07.10.24
/
50%
€48.85
Target price
07.10.25
€39.19
Performance (%)
-20.99%
End price
08.10.25
€38.60
Summary
This prediction ended on 08.10.25 with a price of €38.60. The prediction for Bristol-Myers Squibb closed with a convincing performance of -20.99%. Barclays_PLC has a follow-up prediction for Bristol-Myers Squibb, but this time predicts that Bristol-Myers Squibb is a Buy. Dividends of €0.60 are taken into consideration when calculating the performance. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Bristol-Myers Squibb | 0.685% | 0.685% | -3.106% |
| iShares Core DAX® | 0,39 % | 0,15 % | 10,96 % |
| iShares Nasdaq 100 | 1,31 % | -2,55 % | -0,61 % |
| iShares Nikkei 225® | -0,46 % | 6,89 % | 26,75 % |
| iShares S&P 500 | 1,31 % | -1,16 % | -0,04 % |
Comments by Barclays_PLC for this prediction
In the thread Bristol-Myers Squibb diskutieren
Bristol-Myers Squibb (NYSE: BMY) had its price target raised by analysts at Barclays PLC from $42.00 to $43.00. They now have an "underweight" rating on the stock.
Ratings data for BMY provided by MarketBeat
In the thread Trading Bristol-Myers Squibb
Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten
Current prediction by Barclays_PLC for Bristol-Myers Squibb
Stopped prediction by Barclays_PLC for Bristol-Myers Squibb
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€42.92
22.08.24
22.08.24
€37.80
22.08.25
22.08.25
-4.19%
23.08.25
23.08.25
